Neural Correlates In Mild Alzheimer's Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

July 23, 2007

Primary Completion Date

August 15, 2008

Study Completion Date

August 15, 2008

Conditions
Alzheimer's Disease
Interventions
DRUG

Donepezil hydrochloride

Donepezil hydrochloride 5 mg per day orally, once daily for 4 weeks, followed by 10 mg per day (two 5-mg tablets) for 8 weeks

Trial Locations (1)

53226

Medical College of Wisconsin, Milwaukee

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Eisai Inc.

INDUSTRY

NCT00477659 - Neural Correlates In Mild Alzheimer's Disease | Biotech Hunter | Biotech Hunter